Patients with coronavirus disease 19 (COVID-19) commonly show abnormalities of liver
tests (LTs) of undetermined cause. Considering drugs as tentative culprits, the current …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has been a serious threat to
global health for nearly 3 years. In addition to pulmonary complications, liver injury is not …

Background and aims SARS-CoV-2 has primary pulmonary impairment, but other organs
such as the liver can also be affected. This implies a worsening of patient's prognosis and an …

Abstract Coronavirus disease-19 (COVID-19), primarily a respiratory syndrome, has
emerged as a multisystem disease and affected the liver too, manifested by the elevation of …

Abstract Coronavirus disease 2019 (COVID-19) combined with liver injury has become a
very prominent clinical problem. Due to the lack of a clear definition of liver injury in patients …

Clinical features of Coronavirus 19 disease (COVID-19) are variably described due to
confounding factors such as pre-existing or concomitant disease, drug treatment, and …

Background and Objectives: SARS-CoV-2 infection is frequently associated with pneumonia
but has a broad tissue tropism also leading to systemic complications (hematologic, gastro …

BACKGROUND In patients with liver failure (LF), the high rate of secondary infections, which
are associated with poor prognosis, highlights the clinical significance of understanding the …

Methods: We chose 109 patients with COVID-19 in 2020 and studied the relationship
between gender, age, basic diseases, antiviral drug treatment, disease classification, and …

Infection due to SARS-CoV-2 is associated with clinical features of diverse severity. Severe
disease includes biological criteria of both inflammation and coagulation activation, and …